Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NAPOLEON B HIGGINS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1801814363
CMS profile
263247
Location
FRIENDSWOOD, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$268,611.07

331 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 7 of 7; records 301–331 of 331 matching records. This page contains 31 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NAPOLEON B HIGGINS

NPI 1801814363 · CMS profile ID 263247

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

FRIENDSWOOD, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 7 of 7; records 301–331 of 331 matching records. This page contains 31 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801814363?year=2025&recipient=provider&page=7#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NAPOLEON B HIGGINS, NPI 1801814363, CMS profile ID 263247. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 7; records 301–331 of 331 matching records. This page contains 31 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801814363?year=2025&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). NAPOLEON B HIGGINS, NPI 1801814363, CMS profile ID 263247. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 7; records 301–331 of 331 matching records. This page contains 31 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801814363?year=2025&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
NAPOLEON B HIGGINS, NPI 1801814363, CMS profile ID 263247, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 7 of 7; records 301–331 of 331 matching records. This page contains 31 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1801814363?year=2025&recipient=provider&page=7#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

331 matching records · $268,611.07 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 331 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 301–331 of 331.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Vanda Pharmaceuticals Inc. $211.3502/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971417 CMS
E.R. Squibb & Sons, L.L.C. $122.1002/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184955754 CMS
Vanda Pharmaceuticals Inc. $124.9702/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232971405 CMS
Vanda Pharmaceuticals Inc. $2,100.0002/20/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1232971407 CMS
Vanda Pharmaceuticals Inc. $482.5902/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971409 CMS
Vanda Pharmaceuticals Inc. $437.6002/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971411 CMS
Vanda Pharmaceuticals Inc. $31.2602/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232971397 CMS
Vanda Pharmaceuticals Inc. $2,730.0002/19/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1232971399 CMS
Vanda Pharmaceuticals Inc. $482.5902/19/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971401 CMS
Vanda Pharmaceuticals Inc. $437.6002/19/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971403 CMS
E.R. Squibb & Sons, L.L.C. $6,611.0002/18/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1184955746 CMS
E.R. Squibb & Sons, L.L.C. $43.0602/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184955744 CMS
E.R. Squibb & Sons, L.L.C. $56.0002/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184955748 CMS
ABBVIE INC. $24.8402/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202044055 CMS
Vanda Pharmaceuticals Inc. $26.3302/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232971389 CMS
Vanda Pharmaceuticals Inc. $2,730.0002/12/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1232971391 CMS
Vanda Pharmaceuticals Inc. $1,833.6202/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971393 CMS
Vanda Pharmaceuticals Inc. $299.5902/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971395 CMS
Vanda Pharmaceuticals Inc. $123.8402/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232971377 CMS
Vanda Pharmaceuticals Inc. $3,150.0002/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1232971379 CMS
Vanda Pharmaceuticals Inc. $583.9702/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971381 CMS
Vanda Pharmaceuticals Inc. $130.4302/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971383 CMS
Vanda Pharmaceuticals Inc. $60.0002/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232971385 CMS
Vanda Pharmaceuticals Inc. $26.5202/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232971387 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $85.0801/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222992221 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.1501/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241335012 CMS
Tris Pharma Inc $32.2001/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1192283801 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $65.0801/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225322792 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,430.0001/16/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1225322790 CMS
E.R. Squibb & Sons, L.L.C. $2,165.0001/09/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1184955738 CMS
E.R. Squibb & Sons, L.L.C. $4,810.0001/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1184955734 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $50,062.27 107
PY2020 $23,185.69 40
PY2021 $65,111.23 111
PY2022 $54,540.38 106
PY2023 $97,860.37 149
PY2024 $159,217.53 257
PY2025 $268,611.07 331

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $162,935.12 101
PY2024 Principal investigator $219,236.25 79
PY2020 Principal investigator $2,478.50 4
PY2019 Principal investigator $4,020.30 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

101 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $680.92 12/31/2025 Non-covered Recipient Entity
SCLA MANAGEMENT LLC
A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in Pediatric Subjects (10 to 17 years of age) in the Treatment of Depressive Episodes Associated with Bipolar I Disorder No dispute reported 06/30/2026 1202532458
Principal investigator 1 ACADIA Pharmaceuticals Inc $605.00 12/08/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245938638
Principal investigator 1 ABBVIE INC. $19,700.00 12/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT LLC
A Study of the Change in Disease State and Safety of Oral Cariprazine Capsules in the Treatment of Depression in Pediatric Participants (10 to 17 Years of Age) With Bipolar I Disorder No dispute reported 06/30/2026 1202527178
Principal investigator 1 ACADIA Pharmaceuticals Inc $753.20 12/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245938125
Principal investigator 1 ACADIA Pharmaceuticals Inc $7,532.00 12/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245938133
Principal investigator 1 ACADIA Pharmaceuticals Inc $9,789.00 12/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245938217
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 12/01/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242367915
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 12/01/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242367917
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 12/01/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242367919
Principal investigator 1 ACADIA Pharmaceuticals Inc $500.00 11/21/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-008 No dispute reported 06/30/2026 1245938071
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $150.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242366179
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242366181
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242366183
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $50.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242366189
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $500.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242366191
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242366193
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $500.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242366195
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 11/19/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242366197
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,000.00 11/05/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242365341
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 11/05/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242365343
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 11/05/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242365345
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 11/05/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242365369
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 11/05/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242365371
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 11/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242365127
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 11/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242365129
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,000.00 11/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242365131
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 11/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242365133
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 11/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242365135
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 11/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242365281
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 11/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242365283
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,389.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364427
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $135.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364429
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,389.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364431
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $135.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364433
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $45.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364435
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,806.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364437
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,465.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364439
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,465.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364441
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,354.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364443
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,465.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364445
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,465.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364447
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,693.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364449
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $61.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364451
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $61.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364453
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $61.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364455
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $61.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364457
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $149.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364459
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $103.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364461
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $103.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364463
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $103.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364465
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $103.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364467
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $103.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364469
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $45.00 10/22/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242364471
Principal investigator 1 ACADIA Pharmaceuticals Inc $55.00 10/17/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245937346
Principal investigator 1 ACADIA Pharmaceuticals Inc $500.00 10/17/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245937348
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,520.00 10/13/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363767
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 10/13/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363769
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 10/13/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363771
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 10/13/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363785
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $500.00 10/13/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363787
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 10/13/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363789
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $50.00 10/10/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363405
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 10/10/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363407
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 10/10/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242363409
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 09/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242358350
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 09/03/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242358352
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,500.00 08/25/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242357846
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,500.00 08/01/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245935439
Principal investigator 1 ACADIA Pharmaceuticals Inc $55.00 08/01/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245935441
Principal investigator 1 ACADIA Pharmaceuticals Inc $750.00 08/01/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245935443
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 07/09/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242353575
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 07/09/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242353577
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 07/07/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242352558
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 07/07/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242352560
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 07/07/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242352566
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 07/07/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242352568
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $550.00 06/20/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242351082
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 06/20/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242351102
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 06/20/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242351104
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,500.00 06/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-008 No dispute reported 06/30/2026 1245934277
Principal investigator 1 ACADIA Pharmaceuticals Inc $7,532.00 04/25/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ACP-204-006 No dispute reported 06/30/2026 1245934119
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/09/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242340798
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/09/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242340800
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339333
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339357
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339359
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $500.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339361
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339363
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339365
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339367
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,000.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339462
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339464
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/04/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-421 No dispute reported 06/30/2026 1242339466
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $500.00 04/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242338879
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242338881
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242338883
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242338891
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242338893
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $250.00 04/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242338941
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $650.00 04/02/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-601 No dispute reported 06/30/2026 1242338943
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $36,554.00 02/24/2025 Non-covered Recipient Entity
SCLA MANAGEMENT
ITI-007-321 No dispute reported 06/30/2026 1242333020